CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: A case series. Ebrahimi N, Mazdak M, Shaygannejad V, Mirmosayyeb O, et al. Vaccine 2023 Jan 6:S0264-410X(23)00004-X. doi: 10.1016/j.vaccine.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Ebrahimi N, Mazdak M, Shaygannejad V, Mirmosayyeb O, et al. CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: A case series. Vaccine 2023 Jan 6:S0264-410X(23)00004-X. doi: 10.1016/j.vaccine.2023.
PMID: 36635139